Acuta Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-30,000	Closed	-$2.78M	–	44
2016 Q3	$2.78M	Sell	30,000 -34,000	-53%	-$3.15M	1.04%	26
2016 Q2	$4.98M	Buy	+64,000	New	+$4.98M	2.39%	12